PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironmentCéline Godfroid(University of Lausanne), Pedro Romero(Ludwig Cancer Research)Journal for ImmunoTherapy of CancerJanuary 1, 202510.1136/jitc-2024-009832Cited by 4SaveCiteExport RISWatch citationsRelated PapersMicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer|Immunity|2013|305The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function|Cell Metabolism|2022|190